findmyKOL
Clinical trialNCT01930864UnknownPhase 2Interventional

Metformin Plus Irinotecan for Refractory Colorectal Cancer

SponsorBarretos Cancer HospitalEnrollment41AdenocarcinomaColorectal Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil
  • Barretos Cancer Hospital

    Barretos, São Paulo, Brazil

    Arinilda C Bragagnoli, MD
    Recruiting
  • State University of Campinas

    Campinas, São Paulo, Brazil

    Ligia T Macedo, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Sept 2015
Primary completion
1 Dec 2020
Completion
1 Dec 2020
Last update posted
22 Jun 2017
Registered enrollment
41
Registry id
NCT01930864
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.